Pleiotropic Effects of Statins and Early Benefit in the PROVE IT-TIMI-22 Study

Journal of the American College of Cardiology

Volumn 48, Issue 4, 2006, Pages 852-

  Poli, Andrea ^a   Pujia, Arturo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ACUTE CORONARY SYNDROME; APHERESIS; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EARLY INTERVENTION; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PLEIOTROPY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CHOLESTEROL, LDL; ENDPOINT DETERMINATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; PRAVASTATIN; PYRROLES; REPRODUCIBILITY OF RESULTS;

EID: 33746824620     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.039     Document Type: Letter

References (3)

1. Ray K.K., Cannon C.P., McCabe C.H., et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes. results from the PROVE-IT-TIMI-22 trial. J Am Coll Cardiol 46 (2005) 1405-1410
2. Robinson J.G., Smith B., Maheshwari N., and Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 46 (2005) 1855-1862
3. Igarashi K., Tsuji M., Nishimura M., and Horimoto M. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia. J Clin Apheresis 19 (2004) 11-16